Fidelity Investments — 2023 Investments
4 investments dated 2023 · listed companies and verified rows first · show all
Agomab is a clinical-stage biopharmaceutical company developing disease-modifying therapies for fibro-inflammatory and fibrotic diseases with high unmet medical need.
BiotechHealthtechMedical DevicesAntwerp, BE
Tim Knotnerus(Chief Executive Officer)
Co-investorsEQT Life SciencesAdBio partnersAndera PartnersAsabys PartnersCanaan PartnersPontifax Venture Capital+1 more
Aledade is an accountable care organization (ACO) partner that works with primary care organizations to improve patient outcomes and healthcare quality.
Enterprise SoftwareHealthtechBethesda, US
Bijan Salehizadeh(Co-founder)Farzad Mostashari(Chief Executive Officer and Co-Founder)inMat Kendall(President and Co-Founder)in
BoardRobert Kocher(Director)in
Co-investorsActivate Venture PartnersARCH Venture PartnersEcho Health VenturesGV (Google Ventures)Intrepid Growth PartnersIVP (Institutional Venture Partners)+12 more
Evozyne designs and builds engineered protein therapeutics using an AI-native platform, focusing on treatments for immune-mediated diseases.
AI & Machine LearningBiotechDeep TechHealthtechChicago, US
Aris Theologis(Executive Officer, Director)Darien Parhad(Executive Officer)Patrick J. Morris(Executive Officer, Director)Rama Ranganathan(Executive Officer, Director)Marc Yoskowitz(CEO)
BoardJeffrey S. Aronin(Director)
Co-investorsParagon Biosciences LLCOrbiMedNVenturesNVIDIAValor Equity Partners
VAST Data builds a global data platform designed to enable AI agents to store, process, and execute tasks.
AI & Machine LearningCloud ComputingData & InfrastructureNew York City, US
Jeff Denworth(Founder)inRenen Hallak(Founder & CEO)inAlon Horev(Founder)in
Co-investors83NorthAlpha Square GroupAspire11Cats.vcClaltechDrive Capital+14 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.